Evoralis
EMEA
Cambridge
,
United Kingdom
Startup
FOUNDED
2016
HEADCOUNT
2-20
FUNDING
Seed
Keywords:
enzymes, directed_evolution, HTP_screening, microfluidics, omics, plastics_recycling
BUSINESS
Evoralis is an early-stage enzyme development company founded in 2021 as a spin-out from the Hollfelder Lab at the University of Cambridge, based in Cambridge, UK. Advisory board includes Juergen Eck, co-founder and former CEO of BRAIN Biotech AG. Initial commercial focus is textile recycling, with interest from major fashion retailers.
BIOTECH INVOLVEMENT
Core: enzyme discovery and optimization platform for sustainable biocatalysis. Evoralis uses a proprietary ultrahigh-throughput microfluidic screening platform (developed in the Hollfelder Lab) that tests millions of enzyme variants in picoliter droplets containing real plastic particles, enabling directed evolution of plastic-depolymerizing enzymes up to 1,000x faster than conventional approaches. Target substrates include PET, nylon, and polyurethane, with the goal of enabling enzymatic recycling of blended and mixed-fiber textiles. Business model is capital-light: enzyme sales and bioprocess licensing rather than operating recycling facilities.
TECHNOLOGY PLATFORM
Metagenomic screening; directed evolution
PRIMARY PRODUCTS
Custom industrial enzymes for food processing, detergents, and biocatalysis